BioSenic S.A. Cash Flow-to-Debt Ratio
BioSenic S.A. cash flow-to-debt ratio. BioSenic S.A. (BIOS) has a Cash Flow-to-Debt Ratio of -0.04x as of December 2024, meaning its operating cash flow of €-1.39 Million could theoretically repay 0% of its total liabilities (€31.55 Million) in one year. Check how aggressively does BioSenic S.A. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BioSenic S.A. (2012–2024)
Cash flow-to-debt ratio of BioSenic S.A. from 2012 to 2024. Historical debt coverage capacity for BioSenic S.A. across 13 annual periods. Check earnings quality score of BioSenic S.A. to evaluate the quality of earnings relative to operating cash generation.
BioSenic S.A. Cash Flow-to-Debt Ratio by Year (2012–2024)
BioSenic S.A. cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for BioSenic S.A.. For the full cash flow conversion analysis, see cash efficiency ratio of BioSenic S.A..
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.07x | €-2.23 Million | €31.55 Million | ▲ +34.2% |
| 2023 | -0.11x | €-3.47 Million | €32.26 Million | ▼ -47.5% |
| 2022 | -0.07x | €-1.91 Million | €26.20 Million | ▲ +84.9% |
| 2021 | -0.48x | €-12.78 Million | €26.54 Million | ▲ +35.6% |
| 2020 | -0.75x | €-16.08 Million | €21.51 Million | ▼ -46.3% |
| 2019 | -0.51x | €-10.40 Million | €20.34 Million | ▲ +15.8% |
| 2018 | -0.61x | €-12.90 Million | €21.26 Million | ▼ -25.5% |
| 2017 | -0.48x | €-11.02 Million | €22.79 Million | ▲ +0.9% |
| 2016 | -0.49x | €-11.37 Million | €23.32 Million | ▲ +7.8% |
| 2015 | -0.53x | €-11.77 Million | €22.24 Million | ▼ -405.8% |
| 2014 | -0.10x | €-3.52 Million | €33.69 Million | ▲ +59.3% |
| 2013 | -0.26x | €-3.27 Million | €12.75 Million | ▲ +25.3% |
| 2012 | -0.34x | €-4.05 Million | €11.78 Million | — |